Related Experiment Videos
Techniques for obtaining differential cell counts from bone marrow trephine biopsy specimens.
1University Department of Pathology, Leeds General Infirmary.
Journal of Clinical Pathology
|May 1, 1988
Summary
Comparing bone marrow aspirates and trephine biopsy specimens revealed differences in cell distribution. An extensive sampling method for trephine biopsies provided more consistent results and topographical data, aiding in the study of bone marrow disorders.
Area of Science:
- Hematology
- Anatomic Pathology
Background:
- Bone marrow aspirates and trephine biopsy specimens are crucial for diagnosing hematological disorders.
- Cellular distribution and marrow architecture provide vital diagnostic information.
- Standardized methods for analyzing these specimens are essential for accurate interpretation.
Purpose of the Study:
- To compare differential cell counts between bone marrow aspirates and trephine biopsy specimens.
- To evaluate two distinct sampling methods for trephine biopsy analysis.
- To assess the utility of trephine biopsy in quantifying bone marrow topography.
Main Methods:
- Differential cell counts were performed on 200 paired bone marrow aspirates and trephine biopsy specimens.
- Two sampling area methods for trephine biopsy specimens were assessed.
- Comparison of cell type distribution and topographical features between the two specimen types.
Main Results:
- Trephine biopsy specimens showed a higher proportion of immature myeloid cells compared to aspirates.
- Aspirates contained relatively more polymorphs and lymphocytes than trephine biopsies.
- An extensive sampling method for trephine biopsies yielded more consistent inter-specimen differences and allowed for topographical assessment.
Conclusions:
- Trephine biopsy, particularly with extensive sampling, offers valuable insights into bone marrow cellularity and architecture.
- This method provides information not typically obtainable from aspirates alone.
- The techniques are practical and can enhance the diagnosis of bone marrow disorders, especially those with prominent architectural disturbances like myelodysplastic syndromes.